XBIT - XBiotech Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5337.11M
Enterprise Value 3307.78M
Trailing P/E N/A
Forward P/E 1-9.56
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.86
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-14.94

Trading Information

Stock Price History

Beta (3Y Monthly) 0.41
52-Week Change 3111.82%
S&P500 52-Week Change 31.68%
52 Week High 311.74
52 Week Low 32.13
50-Day Moving Average 37.43
200-Day Moving Average 38.55

Share Statistics

Avg Vol (3 month) 3195.38k
Avg Vol (10 day) 3175.6k
Shares Outstanding 536.11M
Float 25.18M
% Held by Insiders 143.46%
% Held by Institutions 113.56%
Shares Short (Jul 31, 2019) 42.45M
Short Ratio (Jul 31, 2019) 419.61
Short % of Float (Jul 31, 2019) 411.04%
Short % of Shares Outstanding (Jul 31, 2019) 45.98%
Shares Short (prior month Jun 28, 2019) 42.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.82%
Return on Equity (ttm)-37.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -20.6M
Net Income Avi to Common (ttm)-22.88M
Diluted EPS (ttm)-0.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.92M
Total Cash Per Share (mrq)1.1
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)18.52
Book Value Per Share (mrq)1.69

Cash Flow Statement

Operating Cash Flow (ttm)-18.65M
Levered Free Cash Flow (ttm)-10.13M